Giorgia Giussani, Erica Westenberg, David Garcia-Azorin, Elisa Bianchi, Abdul Hanif Khan Yusof Khan, Ricardo Francisco Allegri, Arife Çimen Atalar, Betul Baykan, Lucia Crivelli, Arianna Fornari, Jennifer A Frontera, Alla Guekht, Raimund Helbok, Fan Kee Hoo, Miia Kivipelto, Matilde Leonardi, Ana Sabsil Lopez Rocha, Francesca Mangialasche, Alessia Marcassoli, Ayse Nur Özdag Acarli, Aynur Ozge, Kameshwar Prasad, Manya Prasad, Ekaterina Sviatskaia, Kiran Thakur, Alberto Vogrig, Maurizio Leone, Andrea Sylvia Winkler
Introduction The aim of this systematic review and meta-analysis was to evaluate the prevalence of thirteen neurological manifestations in people affected by COVID-19 during the acute phase and at three, six, nine and twelve-month follow-up time points. Methods The study protocol was registered with PROSPERO (CRD42022325505). MEDLINE (PubMed), Embase and the Cochrane library were used as information sources. Eligible studies included original articles of cohort studies, case-control studies, cross-sectional studies and case series with ≥5 subjects that reported the prevalence and type of neurological manifestations, with a minimum follow-up of three months after the acute phase of COVID-19 disease...
January 25, 2024: Neuroepidemiology